Litigation Details for DOW PHARMACEUTICAL SCIENCES, INC. v. TOLMAR, INC. (D.N.J. 2015)
✉ Email this page to a colleague
DOW PHARMACEUTICAL SCIENCES, INC. v. TOLMAR, INC. (D.N.J. 2015)
Docket | ⤷ Sign Up | Date Filed | 2015-11-09 |
Court | District Court, D. New Jersey | Date Terminated | 2016-10-20 |
Cause | 35:271 Patent Infringement | Assigned To | Stanley R. Chesler |
Jury Demand | None | Referred To | Cathy L. Waldor |
Patents | 8,288,434; 8,663,699 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in DOW PHARMACEUTICAL SCIENCES, INC. v. TOLMAR, INC.
Details for DOW PHARMACEUTICAL SCIENCES, INC. v. TOLMAR, INC. (D.N.J. 2015)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2015-11-04 | 1 | United States Patent Nos. 8,288,434 (“the ’434 patent”) and 8,663,699 (“the ’699 patent”) arising under….S. Patent and Trademark Office (“PTO”) issued the ’699 patent on March 4, 2014. The ’699 patent claims… THE PATENTS IN SUIT 8. The U.S. Patent and Trademark Office (“…(“PTO”) issued the ’434 patent on October 16, 2012. The ’434 patent claims, inter alia, formulations …. Dow is the assignee of the ’434 patent. A copy of the ’434 patent is attached hereto as Exhibit A. | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |